Stay updated on IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Sign up to get notified when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.

Latest updates to the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page
- Check4 days agoChange DetectedAdded the Locations section and California as a study location. Updated the page to revision v3.3.3 and removed the earlier California Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedDeleted the last known status entry for Megan Daly, MD, University of California, Davis, including the date (2023-04) and verification note.SummaryDifference0.4%

- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page; no visible edits to study details, contacts, locations, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedResults Submitted is now shown, indicating that study results have been submitted. Outdated notices about funding status and 'No Results Posted' have been removed.SummaryDifference0.4%

- Check54 days agoChange DetectedNo significant changes detected in the Study Details page; the content remains the same.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference3%

Stay in the know with updates to IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.